These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14668878)

  • 1. Different directions?
    Bowman L
    Nature; 2003 Dec; 426(6967):712. PubMed ID: 14668878
    [No Abstract]   [Full Text] [Related]  

  • 2. In search of the élite.
    Gewin V
    Nature; 2003 Dec; 426(6967):713-7. PubMed ID: 14668879
    [No Abstract]   [Full Text] [Related]  

  • 3. Genentech makes its first-ever acquisition.
    Hollmer M
    Nat Biotechnol; 2007 Jan; 25(1):4-5. PubMed ID: 17211375
    [No Abstract]   [Full Text] [Related]  

  • 4. Growing against the grain.
    Boyle M
    Fortune; 2004 May; 149(9):148-9, 152, 154 passim. PubMed ID: 15124331
    [No Abstract]   [Full Text] [Related]  

  • 5. Newsmaker interview. Defying skeptics, Richard Scheller thinks Genentech will thrive. Interview by Greg Miller.
    Scheller R
    Science; 2009 May; 324(5927):583. PubMed ID: 19407174
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomanufacturing: a high-growth industry for North Carolina.
    Hartl B
    Drug Discov Today; 2005 Nov; 10(22):1494-7. PubMed ID: 16257370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A very firm handshake: biotech's growing negotiating power.
    Thiel KA
    Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
    [No Abstract]   [Full Text] [Related]  

  • 8. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 9. Dynogen's SPAC.
    Osborne R
    Nat Biotechnol; 2008 Apr; 26(4):360. PubMed ID: 18391998
    [No Abstract]   [Full Text] [Related]  

  • 10. Serono changes tack.
    Sheridan C
    Nat Biotechnol; 2006 Jan; 24(1):5. PubMed ID: 16404376
    [No Abstract]   [Full Text] [Related]  

  • 11. Fates intertwined.
    Cooper GJ
    Nat Biotechnol; 2006 Mar; 24(3):252-4. PubMed ID: 16525372
    [No Abstract]   [Full Text] [Related]  

  • 12. Bio-Vision 2016: the second national framework plan for biotechnology promotion in Korea.
    Hyeon BH; Kim HY; Lee CM; Moon SH; Kim ES; Lee SY
    Biotechnol J; 2008 May; 3(5):591-600. PubMed ID: 18446865
    [No Abstract]   [Full Text] [Related]  

  • 13. Take your partner by the hand..
    Smaglik P
    Nature; 2005 Jun; 435(7046):1281. PubMed ID: 15997477
    [No Abstract]   [Full Text] [Related]  

  • 14. Biogen Idec goes on the auction block.
    Osborne R
    Nat Biotechnol; 2007 Dec; 25(12):1335-6. PubMed ID: 18066011
    [No Abstract]   [Full Text] [Related]  

  • 15. Cheap at any price?
    Ledford H
    Nature; 2007 May; 447(7141):131. PubMed ID: 17495898
    [No Abstract]   [Full Text] [Related]  

  • 16. Advice for partnering with pharma.
    Howard K
    Nat Biotechnol; 2004 Nov; 22(11):1477-9. PubMed ID: 15586421
    [No Abstract]   [Full Text] [Related]  

  • 17. Startups on the menu: Archimedes.
    Albani S
    Nat Biotechnol; 2013 Dec; 31(12):1074. PubMed ID: 24316636
    [No Abstract]   [Full Text] [Related]  

  • 18. Trials and error.
    Jacobs T
    Nat Biotechnol; 2005 Dec; 23(12):1481. PubMed ID: 16333284
    [No Abstract]   [Full Text] [Related]  

  • 19. BIO and biogenerics.
    Feldbaum CB
    Nat Biotechnol; 2005 Jan; 23(1):17; discussion 17. PubMed ID: 15637607
    [No Abstract]   [Full Text] [Related]  

  • 20. Genzyme and Isis strike megadeal.
    Mack GS
    Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.